Article
Community-phenotype-methicillin-resistant Staphylococcus aureus infections: a retrospective chart review of outcomes after treatment with daptomycin.
Clinical therapeutics - 1 Nov 2007
Katz David E, Martone William J
Abstract excerpt
BACKGROUND: Daptomycin, a cyclic lipopeptide antibiotic, was approved by the US Food and Drug Administration (FDA) in September 2003 for the treatment of complicated skin and skin structure infections due to susceptible strains of certain gram-positive microorganisms, including methicillin-resist...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
